Are you Dr. Yang?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 16 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
13400 E Shea Blvd
Scottsdale, AZ 85259Phone+1 480-301-8000Fax+1 614-293-6935
Summary
- Dr. Ming Yang, MD is a board certified nuclear medicine physician in Scottsdale, Arizona. He is currently licensed to practice medicine in Arizona, Florida, and Georgia. He is affiliated with Mayo Clinic Hospital.
Education & Training
- Ohio State University HospitalFellowship, Nuclear Radiology, 2011 - 2012
- Ohio State University HospitalFellowship, Neuroradiology, 2009 - 2010
- Ohio State University HospitalFellowship, Nuclear Radiology, 2007 - 2008
- Shandong Medical UniversityClass of 1993
Certifications & Licensure
- AZ State Medical License 2014 - 2025
- FL State Medical License 2015 - 2025
- MN State Medical License 2015 - 2025
- GA State Medical License 2015 - 2016
- NY State Medical License 2012 - 2015
- OH State Medical License 2007 - 2015
- PA State Medical License 2012 - 2014
- American Board of Nuclear Medicine Nuclear Medicine
- American Board of Radiology Diagnostic Radiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Teflon Granuloma With Active Inflammation: A Cause of Recurrent Trigeminal Neuralgia After Microvascular Decompression: Imaging and Pathological Correlation.Steven Herber, Richard S Zimmerman, Alicia Chen, Ming Yang, Felipe Martinez
Clinical Nuclear Medicine. 2024-12-01 - Lutetium-177 DOTATATE Therapy and Cardiac Outcomes in Patients With Neuroendocrine Tumor and Cardiac Metastases.Isabel G Scalia, Mohamad Bassam Sonbol, Juan M Farina, Milagros Pereyra, Yuxiang Wang
JACC. Cardiooncology. 2024-12-01 - 1 citationsShort-course hypofractionated proton beam therapy, incorporatingF-DOPA PET and contrast-enhanced MRI targeting, for patients aged 65 years and older with newly diagnos...Sujay Vora, Deanna Pafundi, Molly Voss, Matthew Buras, Jonathan Ashman
The Lancet. Oncology. 2024-12-01
Press Mentions
- 2018 a Year of Advancements for Mayo Clinic’s Nuclear Medicine DivisionNovember 27th, 2018